Navigation Links
New hope for heart failure patients
Date:9/1/2009

Since receiving cardiac resychronization, Jakubowski has been taking kickboxing and swim aerobics classes, without fatigue. "I'm 100 percent better -- complete satisfaction," she said. "It's like I'm a new person."

The Food and Drug Administration has approved cardiac resychronization for patients with Class 3 (moderate) and Class 4 (severe) heart failure. Such patients experience marked limitations in physical activity or are unable to do any physical activity at all without discomfort.

"With this study, we have shown that certain patients with early-stage, mild heart failure also can benefit from cardiac resychronization," Wilber said.

The study was presented at the European Society of Cardiology Congress in Barcelona. It was supported by a research grant from Boston Scientific, which makes a cardiac resychronization device. Wilber has received lecture fees and grant support from Boston Scientific.


'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Oldest Heart Patients May Get Most From Warfarin
2. This Guys Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations
3. FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
4. Video: Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Patients
5. ColorAlchemy is Featured on HeartandHome Radio Show and Shares the Secret Color for Instant Calm and Clarity
6. Newer, Better Tests for Heart Attacks
7. Hormone therapy for prostate cancer patients with heart conditions linked to increased death risk
8. Women More Prone to Die in Month After Heart Attack
9. American Beverage Association Response to American Heart Association Statement on Added Sugars
10. Testosterone Therapy May Help Men With Heart Failure
11. Why thick blood protects from a heart attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Steven Reinberg HealthDay ... Pediatricians are urging that all children aged 6 months and ... American Academy of Pediatrics updated their influenza vaccine recommendations to ... of vaccine to build immunity. The AAP also wants parents ... kids the nasal spray vaccine instead of the flu shot ...
(Date:9/22/2014)... today became a founding partner in the Global STEM ... promoting young talent in science, technology, engineering and math ... York Academy of Sciences (NYAS), Malaysian Prime Minister Najib ... Sept. 22. , With the goal of developing over ... by 2020, the initiative will create a host of ...
(Date:9/22/2014)... 2014 This Flash Report is a ... needs for the Prostate Cancer market. , Download the ... strategies for any launching Prostate Cancer product:, ... an increasingly crowded market , Understanding stakeholder ... identifying community-based thought leaders and stakeholders ,Download the ...
(Date:9/22/2014)... London, UK (PRWEB) September 22, 2014 ... growth in the recent years. The statistically important data ... and safety of cancer vaccines. The primary challenge to ... sufficient information about the exact mechanism of how a ... leads to various results in different individuals owing to ...
(Date:9/22/2014)... -- Two new prescription devices approved by the U.S. ... for people with migraine headaches who don,t tolerate migraine ... device -- the Cefaly -- is designed to prevent ... is meant to be used when migraines first start, ... been looking for alternative migraine treatments. Because these devices ...
Breaking Medicine News(10 mins):Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Prostate Cancer Products 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 3Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 4Health News:Noninvasive Devices May Help Migraines, FDA Says 2
... or two,have a significantly lower risk of having a ... epidemiologists at the University at Buffalo have shown. ... in the study who reported being,intoxicated at least once ... a heart attack than abstainers, results showed. ...
... authorities in Vietnam confirmed Wednesday the possibility that a resident ... have contracted the lethal H5N1 strain of the bird flu ... ,A fresh outbreak of bird flu has hit five ... H5N1 strain after being hospitalized in serious condition. ...
... drinking water, researchers said. ,There are strong grounds ... can reduce the risk of heart attacks. ... it is a wrong belief that tea leads to dehydration. ... antioxidants. It does not dehydrate you, Mirror quoted Ruxton, as ...
... that combination asthma therapy, SYMBICORT leads to significant ... greater patient-reported satisfaction with asthma treatment, versus ... ,SYMBICORT is a recently approved, combination therapy ... in patients 12 years of age and older. ...
... researcher at the Biodesign Institute at Arizona State University has ... stability and functions in comparison with the ones that occurred ... claims to have evolved several new proteins in a fraction ... ,The new findings have led to some surprisingly new ...
... researcher has revealed that fish possessed the genes associated with ... with limbs (tetrapods) came onto the scene about 365 ... in the Nature, Dr Marcus Davis said, the findings overturned ... was a novel evolutionary event and required the descendents of ...
Cached Medicine News:Health News:Moderate Drinking Lowers Women's Risk of Heart Attack 2Health News:Combo Therapy may Be Highly Beneficial in Asthma Control 2Health News:Genes Associated With Limb Development is More Primitive Than Believed 2
(Date:9/22/2014)... 22, 2014 Research and Markets  has ... Neurotechnology: 2014-2018" report to their offering. ... most comprehensive and up-to-date publication available covering the neurotechnology ... technology, markets, competitors, and growth rates in four key ... through 2018. It forecasts the number of systems to ...
(Date:9/22/2014)... Sept. 22, 2014 Research and Markets ... and Other Novel Hypercholesterolemia Drugs" report to their ... is a high cholesterol burden despite the presence of ... the available options, statins have been ubiquitously prescribed over ... of plasma LDL cholesterol (LDLC) is the cornerstone of ...
(Date:9/22/2014)... , September 22, 2014 Persistence ... on "Global Market Study on Ophthalmic Devices: ... the global ophthalmic devices market was valued at USD 29,171.5 million ... CAGR of 6.5% from 2014 to 2020, to reach ... Browse the full Global Market Study on Ophthalmic ...
Breaking Medicine Technology:The Market for Neurotechnology: 2014-2018 2PCSK9 and Other Novel Hypercholesterolemia Drugs 2PCSK9 and Other Novel Hypercholesterolemia Drugs 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5
... , COCKEYSVILLE, Maryland, November 2 ... Iron Phosphate Technology,to New Levels. , ... high-tech,batteries for industry, has expanded its range of lithium technologies ... phosphate,cell on the market. These large cells are designed for ...
... Shire plc (LSE: SHP, Nasdaq: SHPGY ... a major medical meeting from a Phase IIIb study of ... (methylphenidate transdermal system) in adolescents aged 13 to 17 years ... In addition, data regarding the pharmacokinetic profile of Daytrana in ...
Cached Medicine Technology:Saft Develops Super-Phosphate(TM) Technology for Rigorous Defense Applications 2Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 2Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 3Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 4Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 5Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 6Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 7
... of fibre bronchoscopy: The HF-compatible V series ... other fibre bronchoscopes are measured., ,The ... including the FB-19TV, FB-18V and FB-15V models ... the pediatric FB-8V, offer much better image ...
... High performance fiberoptic imaging from ... ,Olympus has improved its fiberscope range, ... specifications and enhanced image performance. Olympus ... instruments for diagnosis and therapy in ...
... performance fiberoptic imaging from the latest ... improved its fiberscope range, focussing on ... enhanced image performance. Olympus has a ... diagnosis and therapy in the respiratory ...
Slim bronchoscope designed for paediatric applications....
Medicine Products: